Medical Devices

Aerin Medical's milestone highlights a major shift toward minimally invasive, in-office treatments for chronic nasal issues, moving beyond traditional surgery.

A new FDA-cleared device uses water vapor to ablate prostate tissue, showing high efficacy in trials while minimizing life-altering side effects.

Riding high on record 2025 results and a new FDA approval, LivaNova faces intense scrutiny ahead of its May 6 earnings call. Can it sustain the momentum?

With cash dwindling and no FDA approval, ENDRA is exploring a sale. Will its innovative TAEUS® liver scanner find a champion or fade into obscurity?

A new partnership aims to bring therapy animals to 100,000 patients and staff, tackling burnout with a dose of compassion and scientific backing.

A new study reveals Kansas City University's $498.9M annual economic impact, fueling jobs and tackling critical physician shortages across the Midwest.

SciTech's ST-001 overcomes a decades-old barrier for fenretinide, showing promising results for Cutaneous T-Cell Lymphoma patients in early trials.

New data reveals Otsuka's VOYXACT clears key markers of kidney damage in IgA nephropathy, offering new hope beyond symptom management for patients.

Bold Laser Automation's new platform uses 'cold ablation' UV laser technology to clean sensitive parts without heat damage, a leap for medical and tech manufacturing.

A deepening helium shortage, driven by Mideast conflict, threatens the global tech industry and sparks a high-stakes hunt for new, stable sources.

With CE Mark approval, Countable Labs brings single-molecule counting PCR to Europe, promising unprecedented precision for gene therapy and diagnostics.

Health Canada greenlights MeMed's rapid diagnostic tool, a major step in the nation's fight against deadly sepsis and growing antimicrobial resistance.

With $138M in total funding, Endogenex is advancing a novel device that aims to redefine type 2 diabetes treatment by healing the gut, not just managing symptoms.

Biolojic Design's adaptive AI drug for asthma and eczema hits a key milestone with Teva, heralding a new era for personalized autoimmune treatment.

From the heart of Arabia, AlUla Peregrina brings a patented active to the global stage, promising scientifically-backed, ethical longevity beauty.

As funding expires for Wayne State's 35-year heart experiments on dogs, advocates and lawmakers urge the NIH to end a legacy of waste and suffering.

A 50% surge in surrogate insurance demand signals India's new regulated era, but experts warn that inadequate coverage leaves surrogate mothers at grave risk.

Venture capital leaders and national security experts caution that drug pricing controls and regulatory hurdles could cede America's biomedical edge to rivals.

Pixee Medical's AR glasses are challenging costly robots, offering surgeons a new, highly accurate, and efficient way to perform knee replacements.

A new AI-driven, non-invasive test could solve the diagnostic puzzle of INOCA, a heart condition that disproportionately affects millions of women.